About
Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Eyesense AGNon Executive Directorcurrent2024 — present
- Nucleome TherapeuticsNon Executive Directorcurrent2020 — present
- Carrick TherapeuticsNon Executive Directorcurrent2021 — present
- Mission TherapeuticsNon Executive Directorcurrent2021 — present
- Rosetta CapitalFounder & Directorcurrent2009 — present
- Oxford Science EnterprisesStrategic Advisorcurrent2020 — present
- Aprea ABNon-Executive Director2015 — 2020Stockholm, Sweden
- Clanotech ABNon-Executive Director2013 — 2020
- NovimmuneNon-Executive Director2014 — 2016
- ProCertus BioPharm Inc.Non-Executive Director2014 — 2015
- Axelar ABNon-Executive Director2013 — 2015
- Opsona TherapeuticsNon-Executive Director2012 — 2013
- Covagen AGNon-Executive Director2010 — 2013
- Seroba-Kernel Life SciencesPartner2009 — 2013
- BioScience Managers LtdFounder & Director2001 — 2008
- Rothschild Asset ManagementInvestment Analyst1998 — 2000
- ICRFPh.D student1993 — 1998Cambridge University
Skills & more
Start-ups25Venture Capital87Biotechnology39Lifesciences47Drug Discovery21Valuation4Investments33Licensing3Patents1Pharmaceutical Industry36R&D5Biopharmaceuticals24
+10 more
Technology TransferJoint VenturesNon-Executive DirectorMedical DevicesCorporate DevelopmentScienceCommercializationMarket AnalysisStrategyIntellectual PropertyFrom Jonathan's professional profile.
Investments
Board seats
Aprea TherapeuticsCarrick TherapeuticsCatalyst BiosciencesCovagenGlycoMimeticsMission TherapeuticsNovimmuneNucleome TherapeuticsOpsonaParatekTranzyme
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Frequently asked questions
- Who is Jonathan Hepple?
- Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.
- Where does Jonathan Hepple work?
- Jonathan Hepple is Managing Partner at Rosetta Capital Ltd..
- What does Jonathan Hepple invest in?
- Jonathan Hepple invests in Biotech.
- What boards does Jonathan Hepple sit on?
- Jonathan Hepple holds tracked board seats at Aprea Therapeutics, Carrick Therapeutics, Catalyst Biosciences, Covagen, GlycoMimetics, Mission Therapeutics, Novimmune, Nucleome Therapeutics, Opsona, Paratek.
- Where did Jonathan Hepple go to school?
- Jonathan Hepple studied at University of Cambridge (PhD, Cancer Research); University of Oxford (Biology).
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended University of Oxford990
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 984 more
